550 related articles for article (PubMed ID: 6895713)
1. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
Wasserstrom WR; Glass JP; Posner JB
Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.
Twijnstra A; van Zanten AP; Nooyen WJ; Ongerboer de Visser BW
J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid biochemical markers of central nervous system metastases.
Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
[TBL] [Abstract][Full Text] [Related]
5. A review of leptomeningeal metastases in pediatrics.
Chamberlain MC
J Child Neurol; 1995 May; 10(3):191-9. PubMed ID: 7642887
[TBL] [Abstract][Full Text] [Related]
6. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
[TBL] [Abstract][Full Text] [Related]
7. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
9. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report.
Pan Z; Yang G; Yuan T; Pang X; Wang Y; Qu L; Dong L
BMC Cancer; 2014 Jun; 14():399. PubMed ID: 24893802
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.
Levin VA; Chamberlain M; Silver P; Rodriguez L; Prados M
Cancer Chemother Pharmacol; 1989; 23(5):301-7. PubMed ID: 2706735
[TBL] [Abstract][Full Text] [Related]
12. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
13. [Diffuse metastatic leptomeningeal carcinomatosis (DMLC)].
Ishikura A; Hunaki N
Gan No Rinsho; 1987 Jul; 33(8):881-4. PubMed ID: 3613110
[TBL] [Abstract][Full Text] [Related]
14. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
16. Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.
Twijnstra A; van Zanten AP; Hart AA; Ongerboer de Visser BW
J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):313-20. PubMed ID: 3559613
[TBL] [Abstract][Full Text] [Related]
17. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
18. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
19. 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
Mason WP; Yeh SD; DeAngelis LM
Neurology; 1998 Feb; 50(2):438-44. PubMed ID: 9484369
[TBL] [Abstract][Full Text] [Related]
20. Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab.
Kordbacheh T; Law WY; Smith IE
Breast; 2016 Apr; 26():54-8. PubMed ID: 27017242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
